Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-01
2005-11-01
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S425000
Reexamination Certificate
active
06960610
ABSTRACT:
The present invention provides methods which may effectively be used in the treatment and prevention of early cardiac and early cardiovascular diseases, for example of ischemic origin, such as left ventricular hypertrophy, coronary artery disease, essential hypertension, acute hypertensive emergency, cardiomyopathy, heart insufficiency, exercise tolerance, chronic heart failure, arrhythmia, cardiac dysrhythmia, syncopy, arteriosclerosis, mild chronic heart failure, angina pectoris, cardiac bypass reocclusion, intermittent claudication (arteriosclerosis oblitterens), diastolic dysfunction and systolic dysfunction, as well as improving the success of heart transplantations, through administration of glycogen phosphorylase inhibitor compounds.
REFERENCES:
patent: 5998463 (1999-12-01), Hullin et al.
patent: 6277877 (2001-08-01), Hoover et al.
patent: 6570013 (2003-05-01), Mylari
patent: 2001 16399 (2001-07-01), None
patent: 0846464 (1997-12-01), None
patent: 1 125 580 (2001-08-01), None
patent: WO 95/24391 (1995-09-01), None
patent: WO 96/39384 (1996-12-01), None
patent: WO 97/09040 (1997-03-01), None
patent: 00/47206 (2000-08-01), None
patent: WO 01/23347 (2001-04-01), None
Goodman and Gilman's The Pharmacological Basis of Therapeutics, 6thed., published 1980 (p. 749).
Grundy, The New England Journal of Medicine, vol. 319, No. 1,(1988), pp 24-33.
Dragsted Nils
Iversen Lars
Kristiansen Marit
Nyborg Niels Chresten Berg
Rytved Klaus Asger
Began Marc A.
Green Reza
Henley III Raymond J.
Novo Nordick A/S
Wilk-Orescan Rosemarie R.
LandOfFree
Use of glycogen phosphorylase inhibitors for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of glycogen phosphorylase inhibitors for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of glycogen phosphorylase inhibitors for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3501062